Jeffrey M. Boertien

Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment

Sygrid van der Zee, Prabesh Kanel, Marleen J. J. Gerritsen et al. · Movement Disorders · 2022 · 77 citations · Full text

Medicine, Neurology, Neuroscience +17

A <scp>Large‐Scale</scp> Full <scp><i>GBA1</i></scp> Gene Screening in Parkinson's Disease in the Netherlands

Jonas M. den Heijer, Valerie Cullen, Marialuisa Quadri et al. · Movement Disorders · 2020 · 72 citations · Full text

Life Sciences, Genetics, Neurology +11

Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones

Despina Serlidaki, Maria A.W.H. van Waarde, Lukas Rohland et al. · Journal of Biological Chemistry · 2020 · 62 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology

Jeffrey M. Boertien, Sygrid van der Zee, Asterios Chrysou et al. · BMC Neurology · 2020 · 31 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease

Jeffrey M. Boertien, Kirsi Murtomäki, Pedro A. B. Pereira et al. · npj Parkinson s Disease · 2022 · 30 citations · Full text

Life Sciences, Microbiology, Medical Microbiology +16